Risk factors for antimicrobial resistance in patients with Escherichia coli bacteraemia related to urinary tract infection
12 September 2022
This study aimed to identify risk factors for antimicrobial resistance in Escherichia coli bacteraemia related to UTI.
This study showed a high prevalence of trimethoprim resistance and MDR in patients with E. coli bacteraemia related to UTI. This supports the withdrawal of trimethoprim from first-line treatment of UTIs in patients with risk factors for trimethoprim resistance. It has also identified risk factors for MDR in E. coli bacteraemia.
Further reading: Infection Prevention in Practice
Author(s): James Balfour, Mabel Barclay, Janathan Danial, Carol Philip, Meghan Perry, Michelle Etherson, Naomi Henderson
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
